Akoya Biosciences, Inc.
AKYA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -22% | 13.4% | -18.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59.3% | 67.4% | 62.3% | 57.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -68% | -17.7% | -32.1% | -37% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -94.1% | -38.4% | -56% | -56.8% |
| EPS Diluted | -0.32 | -0.17 | -0.21 | -0.27 |
| % Growth | -88.2% | 19% | 22.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |